ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,743Medicare Part D Prescriptions Filled, Including Refills

Rank: 319 out of 2588

$737K Total Retail Price of All Prescriptions

Rank: 202 out of 2588

241 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 241 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 241 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,439 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
WARFARIN SODIUM 577 507 1 10
NAMENDA 521 500 2 32
FUROSEMIDE 335 301 3 5
LEVOTHYROXINE SODIUM 306 278 4 2
LISINOPRIL 270 265 5 3
ESCITALOPRAM OXALATE 264 233 6 68
METOPROLOL TARTRATE 244 232 7 9
MIRTAZAPINE 243 243 8 63
DONEPEZIL HCL 210 208 9 22
AMLODIPINE BESYLATE 209 204 10 4
SIMVASTATIN 208 208 11 1
OMEPRAZOLE 188 172 12 6
HYDROCODONE-ACETAMINOPHEN 174 145 S3 13 7
EXELON 167 148 14 118
POLYETHYLENE GLYCOL 3350 167 143 14 55
PANTOPRAZOLE SODIUM 140 126 16 28
RISPERIDONE 126 124 17 57
IPRATROPIUM-ALBUTEROL 124 122 18 104
CITALOPRAM HBR 121 121 19 27
ATORVASTATIN CALCIUM 120 116 20 11
LIDODERM 118 118 21 86
BUSPIRONE HCL 116 92 22 173
POTASSIUM CHLORIDE 111 102 23 15
GABAPENTIN 110 93 24 18
LEXAPRO 103 91 25 182
BUMETANIDE 102 81 26 117
CARVEDILOL 101 88 27 20
NYSTATIN 96 35 28 196
LEVOFLOXACIN 86 77 29 77
TRAZODONE HCL 82 71 30 61
KLOR-CON M20 79 67 31 52
NYSTATIN-TRIAMCINOLONE 79 69 31 158
ALENDRONATE SODIUM 77 73 33 21
LEVETIRACETAM 74 66 34 90
GLIPIZIDE 73 63 35 44
PRAVASTATIN SODIUM 71 64 36 16
PREDNISONE 68 53 37 42
LANTUS 67 33 38 47
ABILIFY 64 58 39 134
TRAMADOL HCL 63 61 40 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 58 40 127
KLOR-CON M10 63 54 40 139
ATENOLOL 62 62 43 14
METFORMIN HCL 61 57 44 8
FLUTICASONE PROPIONATE 61 61 44 40
SERTRALINE HCL 61 61 44 26
HEPARIN SODIUM 61 29 44 79
FAMOTIDINE 58 47 48 36
QUETIAPINE FUMARATE 58 55 48 74
IPRATROPIUM BROMIDE 58 13 48 159
ALBUTEROL SULFATE 56 32 51 116
CLOPIDOGREL 53 53 52 30
HYDROCHLOROTHIAZIDE 52 52 53 13
METOPROLOL SUCCINATE 52 50 53 12
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.